• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
81,757.73 -501.51
( -0.61%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.90 3.35
( 0.01%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,992.12 19.48
(0.22%)
Forex
USD-INR
85.99 0.08
(0.09%)
EUR-INR
99.75 -0.09
(-0.09%)
GBP-INR
115.25 0.11
(0.09%)
JPY-INR
0.58 0.00
(0.02%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
57.95
1153.36
EPS(TTM)
Face Value()
Div & Yield %
16.89
10
0
 

Johnson Pharmacare reports standalone net loss of Rs 0.51 crore in the March 2025 quarter
May 24,2025
Net loss of Johnson Pharmacare reported to Rs 0.51 crore in the quarter ended March 2025. There were no net profit/loss reported during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.58 crore in the year ended March 2025 as against net loss of Rs 0.20 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.